Skip to content

Evommune, Inc.

EVMN · XNYS

CIK 2044725fmd_0XXG64J0ZXR005N7RPSTT4ZE4YManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2024 to Sep 30, 2026, 9 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading